Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series
ConclusionsThis case series represents the first description of potential skeletal adverse effects related to immune checkpoint inhibitors. These findings are important for providers caring for patients who experience musculoskeletal symptoms and may merit additional evaluation.
Source: Journal for Immunotherapy of Cancer - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Carcinoma | Endocrinology | Immunotherapy | Kidney Cancer | Laboratory Medicine | Lung Cancer | Melanoma | Non-Small Cell Lung Cancer | Orthopaedics | Renal Cell Carcinoma | Rheumatology | Skin Cancer